➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Shilpa Medicare Ltd Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SHILPA MEDICARE LTD, and what generic and branded alternatives to SHILPA MEDICARE LTD drugs are available?

SHILPA MEDICARE LTD has nine approved drugs.

There is one tentative approval on SHILPA MEDICARE LTD drugs.

Summary for Shilpa Medicare Ltd
US Patents:0
Drug Master File Entries: 35

Drugs and US Patents for Shilpa Medicare Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shilpa Medicare Ltd CAPECITABINE capecitabine TABLET;ORAL 207456-002 Dec 12, 2016 AB RX No No   Start Trial   Start Trial
Shilpa Medicare Ltd IMATINIB MESYLATE imatinib mesylate TABLET;ORAL 208302-001 Jan 17, 2019 AB RX No No   Start Trial   Start Trial
Shilpa Medicare Ltd BUSULFAN busulfan INJECTABLE;INJECTION 210931-001 Apr 18, 2019 AP RX No No   Start Trial   Start Trial
Shilpa Medicare Ltd GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 210991-002 Oct 4, 2019 AP RX No No   Start Trial   Start Trial
Shilpa Medicare Ltd DOCETAXEL docetaxel INJECTABLE;INJECTION 210327-002 May 16, 2019 AP RX No No   Start Trial   Start Trial
Shilpa Medicare Ltd ZOLEDRONIC ACID zoledronic acid INJECTABLE;INTRAVENOUS 208513-001 May 15, 2019 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.